The apicoplast as an antimalarial drug target

Drug Resistance Updates

Volumn 4, Issue 3, 2001, Pages 145-151

  Ralph, Stuart A ^a   D'Ombrain, Marthe C ^a   McFadden, Geoffrey I ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMYTHIAMICIN; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; AZITHROMYCIN; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; CLODINAFOP; DOXYCYCLINE; ERYTHROMYCIN; FOSMIDOMYCIN; GLYPHOSATE; HALOXYFOP; ISONIAZID; MICROCOCCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; QUIZALOFOP; RIFAMPICIN; SPIRAMYCIN; TETRACYCLINE; THIOLACTOMYCIN; THIOSTREPTON; TRICLOSAN; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

AMINO ACID SYNTHESIS; ANTIPROTOZOAL ACTIVITY; APICOPLAST; CELL METABOLISM; CHLOROPLAST; DNA REPLICATION; DNA TRANSCRIPTION; DRUG INDUCED DISEASE; DRUG TARGETING; FATTY ACID SYNTHESIS; HEME SYNTHESIS; HUMAN; MALARIA; PLASMODIUM FALCIPARUM; PLASTID; PRIORITY JOURNAL; RNA TRANSLATION; SHORT SURVEY;

EID: 0035188222     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1054/drup.2001.0205     Document Type: Article

References (71)

1. The origin of plastids and their spread via secondary endosymbiosis
2. The plastid in Apicomplexa: What use is it?
3. A plastid organelle as a drug target in apicomplexan parasites
4. A plastid segregation defect in the protozoan parasite Toxoplasma gondii
5. Complete gene map of the plastid-like DNA of the malaria parasite Plasmodium falciparum
6. Anti-Toxoplasma activities of 24 quinolones and fluoroquinolones in vitro: Prediction of activity by molecular topology and virtual computational techniques
7. Use of a LightCycler gyrA mutation assay for rapid identification of mutations conferring decreased susceptibility to ciprofloxacin in multiresistant Salmonella enterica serotype typhimurium DT104 isolates
8. Inhibitory activity of quinolones against DNA gyrase of Mycobacterium tuberculosis
9. Transcription in chloroplasts and mitochondria: A tale of two polymerases
10. Identification and characterization of a Plasmodium falciparum RNA polymerase gene with similarity to mitochondrial RNA polymerases
11. Two components of the chloroplast protein import apparatus, IAP6 and IAP75, interact with the transit sequuence during recognition and translocation of precursor proteins at the outer envelope
12. Plastid in human parasites
13. Plastids in apicomplexan parasites
14. Apicomplexan plastids as drug targets
15. The plastid in Plasmodium falciparum asexual blood stages: A three-dimensional ultrastructural analysis
16. Protein synthesis in the plastid of Plasmodium falciparum
17. Erythromycin, lincomycin and clindamycin
18. Molecular karyotype analysis of Cryptosoridium parvum: Evidence for eight chromosomes and a low-molecular-size molecule
19. The growing importance of the plastid-like DNAs of the Apicomplexa
20. Interconnection between organellar functions, development and drug resistance in the protozoan parasite, Toxoplasma gondii
21. Inhibition of cytoplasmic and organellar protein synthesis in toxoplasma gondii - Implications for the target of macrolide antibiotics
22. Comparison of mutants of Toxoplasma gondii selected for resistance to azithromycin, spiramycin, or clindamycin
23. In vitro assays elucidate peculiar kinetics of clindamycin action against Toxoplasma gondii
24. Inhibition of Plasmodium falciparum protein synthesis: Targeting the plastid-like organelle with thiosrepton
25. Interaction of thiostrepton with an RNA fragment derived from the plastid-encoded ribosomal RNA of the malaria parasite
26. The antibiotic micrococcin is a potent inhibitor of growth and prtein sythesis in the malaria parasite
27. Thiostrepton binds to malarial plastid rRNA
28. The sensitivity of Plasmodium protein synthesis to prokaryotic ribosomal inhibitors
29. Recent advances in the biosynthesis of plant fatty-acids
30. The animal fatty acid synthase: One gene, one polypeptide, seven enzymes
31. Nuclear-encoded proteins target to the plastid in Toxoplasma gondii and Plasmodium falciparum
32. Triclosan offers protection against blood stages of malaria by inhibiting enoyl-ACP reductase of Plasmodium falciparum
33. Enoyl-acyl carrier protein reductase (fabi) plays a determinant role in completing cycles of fatty acid elongation in Escherichia coli
34. Molecular basis of triclosan activity
35. Triclosan: Applications and safety
36. Mechanism of triclosan inhibition of bacterial fatty acid synthesis
37. Triclosan targets lipid synthesis
38. The enoyl-[acyl carrier protein] reductases, Fabl and FabL from Bacillus subtilis
39. Broad spectrum antimicrobial biocides target the Fabl component of fatty acid biosynthesis
40. Inhibition of the Staphylococcus aureus NADPH-dependent enoyl-acyl carrier protein reductase by triclosan and hexachlorophene
41. Inhibition of InhA, the enoyl reductase from Mycobacterium tuberculosis, by triclosan and isoniazid
42. Genetic evidence that InhA of Mycobacterium smegmatis is a target for triclosan
43. Molecular analysis of a Type 1 fatty acid synthase in Cryptosporidium parvum
44. Cryptospotidium parvum appears to lack a plastid genome
45. Inhibitors of de novo fatty acid biosynthesis in higher plants
46. Compartmentalization of two forms of acetyl-CoA carboxylase in plants and the origin of their tolerance toward herbicides
47. Subcellular localization of acetyl-CoA carboxylase in the apicomplexan parasite Toxoplasma gondii
48. Growth of Toxoplasma gondii is inhibited by aryloxyphenoxypropionate herbicides targeting acetyl-CoA carboxylase
49. Herbicide sensitivity determinant of wheat plastid acetyl-CoA carboxylase is located in a 400-amino acid fragment of the carboxyltransferase domain
50. Biosynthesis of isoprenoids in higher plant chloroplasts proceeds via a mevalonate-independent pathway
51. Inhibitors of the nonmevalonate pathway of isoprenoid biosynthesis as antimalarial drugs
52. Tools for discovery of inhibitors of the 1-deoxy-D-xylulose 5-phosphate (DXP) synthase and DXP reductoisomerase: An approach with enzymes from the pathogenic bacterium Pseudomonas aeruginosa
53. The non-mevalonate isoprenoid biosynthesis of plants as a test system for drugs against malaria and pathogenic bacteria
54. Evidence for the shikimate pathway apicomplexan parasites
55. Shikimate pathway in apicomplexan parasites
56. Subcellular localization and characterization of chorismate synthase in the apicomplexan Plasmodium falciparum. PG - 65-75
57. Glu as a cofactor in δ-aminolevulinate biosynthesis: Steps that regulate chlorophyll synthesis
58. De novo biosynthesis of heme offers a new chemotherapeutic target in the human malarial parasite
59. Impact of a plastid-bearing endocytobiont on apicomplexan genomes
60. Characterization of the delta-aminolevulinate synthase gene homologue in P. falciparum
61. Import of host delta-aminolevulinate dehydratase into the malarial parasite: Identification of a new drug target
62. Generation of resistance to the diphenyl ether herbicide acifluorfen by mel cells
63. Antimalarial drug development and new targets
64. Drug resistance in Plasmodium falciparum malaria
65. Efficacy of 101 antimicrobials and other agents on the development of Cryptosporidium parvum in vitro
66. Topoisomerase II inhibitors induce cleavage of nuclear and 35-kb plastid DNAs in the malarial parasite Plasmodium falciparum
67. Activity of fluoroquinolone antibiotics against Plasmodium folciparum in vitro
68. Antimalarial activity of rifampicin in vitro and in rodent models
69. Antimalarial effects of rifampin in Plasmodium vivax malaria
70. Effects of interruption of apicoplast function on malaria infection, development, and transmission
71. Antibiotic inhibitors of organellar protein synthesis in Plasmodium falciparum